Anesthesia for patients older than 65 years represents more risk due to age-related physiological changes and the multiple co-morbidities they often present.
A computer simulation study showed that lower than conventional doses of propofol were adequate to sedate the elderly.
A clinical trial validated the new dose scheme.
Using a lower dose in the elderly minimizes the secondary effects of propofol.